MIAMI (AP) — The Miami Marlins finalized a $13 million, one-year deal with right-handed reliever Pete Fairbanks on Sunday.
He gets a $1 million signing bonus, a $12 million salary and the chance to earn $1 million in performance bonuses for appearances: $100,000 for 30, $200,000 for 40, $300,000 for 50 ad $400,000 for 60. If traded, he would receive a one-time $500,000 assignment bonus from the acquiring team.
The 32-year-old made a career-high 61 appearances with Tampa Bay last season, going 4-5 with a 2.83 ERA. He set a career high with 27 saves in 32 opportunities, while giving up seven home runs and 45 hits in 60 1/3 innings.
Fairbanks also finished last season ranked third among American League relievers in games finished (48) and seventh in saves.
He spent the past seven seasons with the Rays and went 20-22 with a 2.98 ERA. He recorded 96 walks and 317 strikeouts in 267 appearances. He made 12 postseason appearances with the Rays, including nine during the club’s World Series appearance in 2020.
The Rays declined an $11 million option on Fairbanks last month, allowing their closer to become a free agent. Fairbanks got a $1 million buyout.
AP MLB: https://apnews.com/mlb
FILE - Tampa Bay Rays' Pete Fairbanks during the seventh inning of a baseball game against the Cleveland Indians Sunday, Sept. 1, 2019, in St. Petersburg, Fla. (AP Photo/Chris O'Meara, File)
INCHEON, South Korea--(BUSINESS WIRE)--Apr 2, 2026--
The Samsung Biologics Labor Union criticized Samsung Biologics after the Incheon Regional Labor Relations Commission (Case No. Incheon 2025 Discrimination 10) ruled the company’s exclusion of contract workers from holiday gift benefits constituted discriminatory treatment. Following this, the company changed counsel from Bae, Kim & Lee LLC to Kim & Chang, South Korea’s largest and most premium corporate law firm, and filed for review before the National Labor Relations Commission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402905034/en/
The union does not view this as a minor welfare dispute. It is difficult to justify a company with $1.3 billion in operating profit contesting a $10,000 matter (about $66 per worker for 150 contract workers) rather than accepting the outcome. The core issue is the decision to exclude contract workers over such a trivial cost, and then aggressively defend that discrimination instead of correcting it.
While the company reportedly argued the gift was a discretionary CEO benefit, the union stated that treating a negotiated benefit as unilateral generosity reflects a tendency to view people as costs, not organizational members.
The union added this raises broader concerns about human rights and ESG credibility. Excluding workers based on employment status and fighting labor rulings is inconsistent with the company's publicly promoted ESG values. Furthermore, the union warned that management's pattern of making such irrational decisions is driving labor-management relations into a structural conflict. True ESG credibility requires workplace fairness and respect for human dignity.
Jaesung Park, President of the Samsung Biologics Labor Union, said, “The amount at issue may be small, but the discriminatory mindset revealed is not. Such repeated irrational decisions are destroying foundational trust and creating a structural crisis in our labor relations. What the company needs now is not a determination to fight a small cost to the end, but the common-sense decision to correct discrimination and treat people as members of the organization.”
A written judgment from the Labor Relations Commission confirming that Samsung Biologics discriminated against a fixed-term employee regarding holiday benefits.
